Company intelligence / Profile preview
Franco-Indian Pharmaceuticals Pvt. Ltd.
- Ownership
- Private
- Development stage
- Commercial
Overview
Franco‐Indian Pharmaceuticals has a long history of introducing first-in-class products to the Indian market including India’s first oral penicillin and cortisone. Its portfolio covers diabetes care with metformin (“Glyciphage”), hematinics (“Dexorange”), dermatologicals for vitiligo/psoriasis (“Melanocyl”), probiotics (“Lactisyn”), bronchodilators (“A‐Phyl”) and more[3][4][5]. The company’s products are widely available in India and exported internationally.
- Therapeutic areas
- PulmonologyEndocrinologyHematologyDermatologyGastroenterologyWomen's Health
- Modalities
- Small moleculesvitamins/mineralsprobioticscorticosteroids
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Franco-Indian Pharmaceuticals Pvt. Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Franco-Indian Pharmaceuticals Pvt. Ltd..